The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2
Open accessAbstract
Inflammation associates with peripheral insulin resistance, which dysregulates nutrient homeostasis and leads to diabetes. Inflammation induces the expression of SOCS proteins. We show that SOCS1 or SOCS3 targeted IRS1 and IRS2, two critical signaling molecules for insulin action, for ubiquitin-mediated degradation. SOCS1 or SOCS3 bound both recombinant and endogenous IRS1 and IRS2 and promoted their ubiquitination and subsequent degradation in multiple cell types. Mutations in the conserved SOCS box of SOCS1 abrogated its interaction with the elongin BC ubiquitin-ligase complex without affecting its binding to IRS1 or IRS2. The SOCS1 mutants also failed to promote the ubiquitination and degradation of either IRS1 or IRS2. Adenoviral-mediated expression of SOCS1 in mouse liver dramatically reduced hepatic IRS1 and IRS2 protein levels and caused glucose intolerance; by contrast, expression of the SOCS1 mutants had no effect. Thus, SOCS-mediated degradation of IRS proteins, presumably via the elongin BC ubiquitin-ligase, might be a general mechanism of inflammation-induced insulin resistance, providing a target for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“obesity-related insulin resistance could result from a diminution in insulin receptor substrate-1 (IRS-1) in animals, secondary to an increase in suppressor of cytokine signaling 3 (SOCS-3), which binds to IRS-1 and leads to its ubiquitylation and proteolysis in experimental animals [5]”
From Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects (2020) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H. H., Burks, D. J., Ren, J., Previs, S. F., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
SOCS Proteins: Negative Regulators of Cytokine Signaling
Krebs, D. L., & Hilton, D. J. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-378 · Cited by 826
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 688
Zhang, J., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R. T., Hausmann, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2071 · Cited by 626
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 899
Demidowich, A. P., Davis, A. I., Dedhia, N., & Yanovski, J. A. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.04.039 · Cited by 66
Rodríguez‐Calvo, R., Girona, J., Rodríguez, M. M., Samino, S., Barroso, E., de Gonzalo‐Calvo, D., Guaita‐Esteruelas, S., Heras, M., van der Meer, R. W., Lamb, H. J., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.04.007 · Cited by 63
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00987 · Cited by 60
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa108 · Cited by 60
Medeiros, C. D., Frederico, M. J. S., da Luz, G., Pauli, J. R., da Silva, A. S. R., Pinho, R. A., Velloso, L. A., Ropelle, E. R., & de Souza, C. T. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22387 · Cited by 59
Kim, K., Kim, K. H., & Cheong, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008649 · Cited by 62
Borland, G., Bird, R. J., Palmer, T. M., & Yarwood, S. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.015370 · Cited by 58
The Role of Suppressors of Cytokine Signalling in Human Neoplasms
Sasi, W., Sharma, A. K., & Mokbel, K. (2014) · Molecular Biology International · doi:10.1155/2014/630797 · Cited by 60
McCormick, S. M., Gowda, N. M., Fang, J., & Heller, N. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.746164 · Cited by 56
Lew, K. S., Pearson, J. T., Schwenke, D. O., & Katare, R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0484-4 · Cited by 57
Yin, Y., Qu, H., Yang, Q., Fang, Z., & Gao, R. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153749 · Cited by 56
Gharib, S. A., Hayes, A. L., Rosen, M. J., & Patel, S. R. (2012) · SLEEP · doi:10.5665/sleep.2294 · Cited by 56
Pathogenesis of Type 2 Diabetes
Stümvoll, M., Goldstein, B. J., & van Haeften, T. W. (2007) · Endocrine Research · doi:10.1080/07435800701743810 · Cited by 58
Diabetes and Suppressors of Cytokine Signaling Proteins
Rønn, S. G., Billestrup, N., & Mandrup-Poulsen, T. R. (2007) · Diabetes · doi:10.2337/db06-1068 · Cited by 55
Ben‐Zvi, T., Yayon, A., Gertler, A., & Ornan, E. M. (2006) · Journal of Cell Science · doi:10.1242/jcs.02740 · Cited by 56
Recent advances on the biological activities of purple sweet potato anthocyanins
Tang, C., Han, J., Chen, D., Zong, S., Liu, J., Kan, J., Qian, C., & Jin, C. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.102670 · Cited by 62
Kolliputi, N., & Waxman, A. B. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0287oc · Cited by 53
Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy
Recio, C., Lázaro, I., Oguiza, A., Lopez‐Sanz, L., Bernal, S., Blanco, J., Egido, J., & Gómez‐Guerrero, C. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020237 · Cited by 56
Ouyang, H., He, X., Li, G., Xu, H., Jia, X., Nie, Q., & Zhang, X. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160716242 · Cited by 57
Insulin resistance and steatosis in chronic hepatitis C
Machado, M. V., & Cortez‐Pinto, H. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31829-0 · Cited by 55
Forand, A., Koumakis, E., Rousseau, A., Sassier, Y., Journé, C., Merlin, J.-F., Leroy, C., Boitez, V., Codogno, P., Friedlander, G., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.012 · Cited by 57
Ullah, R., Rauf, N., Nabi, G., Shen, Y., Yu-Dong, Z., & Fu, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112012 · Cited by 64
Wada, T., Hoshino, M., Kimura, Y., Ojima, M., Nakano, T., Koya, D., Tsuneki, H., & Sasaoka, T. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00370.2010 · Cited by 57
Control of mTOR Signaling by Ubiquitin
Jiang, Y., Su, S.-Y., Zhang, Y.-Q., Qian, J.-Y., & Liu, P.-D. (2019) · Oncogene · doi:10.1038/s41388-019-0713-x · Cited by 46
Howie, G., Sloboda, D. M., Reynolds, C. M., & Vickers, M. H. (2013) · Journal of Nutrition and Metabolism · doi:10.1155/2013/517384 · Cited by 53
The ubiquitin-proteasome pathway is a new partner for the control of insulin signaling
Rome, S., Meugnier, E., & Vidal, H. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200405000-00002 · Cited by 52
Insulin-Regulated Trafficking of GLUT4 Requires Ubiquitination
Lamb, C. A., McCann, R., Stöckli, J., James, D. E., & Bryant, N. J. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01113.x · Cited by 52
LeRoith, D., & NISSLEY, P. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24228 · Cited by 52
Gokulakrishnan, K., Mohanavalli, K. T., Monickaraj, F., Mohan, V., & Balasubramanyam, M. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9996-x · Cited by 52
Haan, S., Wüller, S., Kaczor, J., Rolvering, C., Nocker, T., Behrmann, I., & Haan, C. (2009) · Oncogene · doi:10.1038/onc.2009.155 · Cited by 51
Waller‐Evans, H., Hue, C., Fearnside, J., Rothwell, A. R., Lockstone, H. E., Caldérari, S., Wilder, S. P., Cazier, J., Scott, J., & Gauguier, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082825 · Cited by 51
SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer
Hoefer, J., Kern, J., Ofer, P., Eder, I. E., Schäfer, G., Dietrich, D., Kristiansen, G., Geley, S., Rainer, J., Gunsilius, E., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0446 · Cited by 52
Palanivel, R., Fullerton, M. D., Galić, S., Honeyman, J. E., Hewitt, K., Jørgensen, S. B., & Steinberg, G. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2665-3 · Cited by 53
Role of Leptin and SOCS3 in Inhibiting the Type I Interferon Response During Obesity
Terán-Cabanillas, E., & Hernández, J. (2016) · Inflammation · doi:10.1007/s10753-016-0452-x · Cited by 56
Signalling links in the liver: Knitting SOCS with fat and inflammation
Farrell, G. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.004 · Cited by 51
Current Studies on Molecular Mechanisms of Insulin Resistance
Pei, J., Wang, B., & Wang, D. (2022) · Journal of Diabetes Research · doi:10.1155/2022/1863429 · Cited by 58
Schattenberg, J. M., & Schuchmann, M. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0366-2 · Cited by 49
Proteasome‐mediated proteostasis: Novel medicinal and pharmacological strategies for diseases
Mishra, R., Upadhyay, A., Prajapati, V. K., & Mishra, A. (2018) · Medicinal Research Reviews · doi:10.1002/med.21502 · Cited by 51
Liver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 51
Growth impairment in IL-6-overexpressing transgenic mice is associated with induction of SOCS3 mRNA
Lieskovská, J., Guo, D., & Derman, E. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00135-1 · Cited by 52
RING-finger E3 ligases regulatory network in PI3K/AKT-mediated glucose metabolism
Wang, W., Shi, B., Cong, R., Hao, M., Peng, Y., Yang, H., Song, J., Feng, D., Zhang, N., & Li, D. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01162-7 · Cited by 51
Adipose “Talks” to Distant Organs to Regulate Insulin Sensitivity and Vascular Function
Zhang, H., & Zhang, C. (2010) · Obesity · doi:10.1038/oby.2010.91 · Cited by 49
The roles of ubiquitin modifying enzymes in neoplastic disease
Kumari, N., Jaynes, P. W., Saei, A., Iyengar, P. V., Richard, J. L. C., & Eichhorn, P. J. A. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.002 · Cited by 51
Non-alcoholic fatty liver disease: From insulin resistance to mitochondrial dysfunction
Herruzo, J. A. S., Ruiz, I. G., Carreras, M. P., & Muñoz-Yagüe, M. T. (2006) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082006001100006 · Cited by 48
García-Hernández, M. H., Portales‐Cervantes, L., Cortez-Espinosa, N., Morales, J. M. V., Fritche‐Salazar, J. F., Rivera-López, E., Rodríguez-Rivera, J., Quezada‐Calvillo, R., & Portales‐Pérez, D. P. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.03.022 · Cited by 48
Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
Perfield, J. W., Lee, Y., Shulman, G. I., Samuel, V. T., Jurczak, M. J., Chang, E., Xie, C., Tsichlis, P. N., Obin, M. S., & Greenberg, A. S. (2011) · Diabetes · doi:10.2337/db10-0715 · Cited by 52
Calegari, V. C., Alves, M., Picardi, P. K., Inoue, R. Y., Franchini, K. G., Saad, M. J. A., & Velloso, L. A. (2004) · Endocrinology · doi:10.1210/en.2004-0466 · Cited by 48
Impaired Central Insulin Response in Aged Wistar Rats: Role of Adiposity
Frutos, M. G.-S., Fernández‐Agulló, T., Solís, A. J. D., Andrés, A., Arribas, C., Carrascosa, J. M., & Ros, M. (2007) · Endocrinology · doi:10.1210/en.2007-0543 · Cited by 48
SOCS-1 Localizes to the Microtubule Organizing Complex-Associated 20S Proteasome
Vuong, B. Q., Arenzana, T. L., Showalter, B. M., Losman, J. A., Chen, X. P., Mostecki, J. W., Banks, A. S., Limnander, A., Fernandez, N., & Rothman, P. B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9092-9101.2004 · Cited by 47
Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression
Zhou, H., Saito, S., Piao, G., Liu, Z.-P., Wang, J., Horimoto, K., & Chen, L. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s1-s16 · Cited by 48
Intestinal microbiota and their metabolic contribution to type 2 diabetes and obesity
Cunningham, A., Stephens, J. W., & Harris, D. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00858-4 · Cited by 49
Arlien-Søborg, M. C., Dal, J., Madsen, M. A., Høgild, M. L., Hjelholt, A. J., Pedersen, S. B., Møller, N., Jessen, N., & Jørgensen, J. O. L. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103763 · Cited by 46
Elongin C (ELOC/TCEB1)-associated von Hippel–Lindau disease
Andreou, A., Yngvadóttir, B., Bassaganyas, L., Clark, G. R., Martín, J., Whitworth, J., Cornish, A. J., Houlston, R. S., Rich, P. M., Egan, C. A., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac066 · Cited by 50
The relationship between inflammatory markers, angiogenesis, and obesity.
Tahergorabi, Z., & Khazaei, M. (2013) · Europe PMC (PubMed Central) · Cited by 46
Barbour, L. A., McCurdy, C. E., Hernandez, T. L., & Friedman, J. E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2116 · Cited by 50
Yaspelkis, B. B., Kvasha, I. A., & Figueroa, T. Y. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00117.2009 · Cited by 48
Insight into miRNAs related with glucometabolic disorder
Zhang, B., Shen, C., Zhu, B.-W., An, H., Zheng, B. J., Xu, S., Sun, J., Sun, P.-C., Zhang, W., Wang, J., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.123 · Cited by 48
Stat3 activation induces insulin resistance via a muscle-specific E3 ubiquitin ligase Fbxo40
Zhang, L., Chen, Z., Wang, Y., Tweardy, D. J., & Mitch, W. E. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00480.2019 · Cited by 47
Wang, Y., Nishina, P. M., & Naggert, J. Κ. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0026 · Cited by 46
Thouvenot, K., Turpin, T., Taïlé, J., Clément, K., Meilhac, O., & Gonthier, M. (2022) · Biomolecules · doi:10.3390/biom12030378 · Cited by 51
Chapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
Boura‐Halfon, S., & Zick, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00612-2 · Cited by 53
Venieratos, P. D., Drossopoulou, G. I., Kapodistria, K., Tsilibary, E. C., & Kitsiou, P. V. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.003 · Cited by 46
Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2)
DeStefano, M. A., & Jacinto, E. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130018 · Cited by 55
Contribution of insulin resistance to vascular dysfunction
Anfossi, G., Russo, I., Doronzo, G., & Trovati, M. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903136791 · Cited by 49
Mrizak, I., Arfa, A., Fekih, M., Debbabi, H., Bouslema, A., Boumaiza, I., Zaouali, M., Khan, N. A., & Tabka, Z. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-93 · Cited by 44
Ghanim, H., Batra, M., Abuaysheh, S., Green, K., Makdissi, A., Kuhadiya, N. D., Chaudhuri, A., & Dandona, P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2669 · Cited by 46
MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway
Wang, T., Chen, G., Ma, X., Yang, Y., Chen, Y., Peng, Y., Bai, Z., Zhang, Z., Pei, H., & Guo, W. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1326-6 · Cited by 47
NUCKS Is a Positive Transcriptional Regulator of Insulin Signaling
Qiu, B., Shi, X., Wong, E. T., Lim, J., Bezzi, M., Low, D., Zhou, Q., Akıncılar, S. C., Lakshmanan, M., Swa, H. L. F., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.030 · Cited by 45
Pinto, L. D. F., Compri, C. M., Fornari, J. V., Bartchewsky, W., Cintra, D. E., Trevisan, M. S., Carvalho, P. D. O., Ribeiro, M. L., Velloso, L. A., Saad, M. J. A., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2009.02200.x · Cited by 46
de Farias, J., Maggi, R. M., Tromm, C. B., da Silva, L. A., Luciano, T. F., Marques, S. M. S., Lira, F. S., de Souza, C., & Pinho, R. A. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-134 · Cited by 45
Cao, L., Wang, Z., & Wan, W. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00417 · Cited by 46
Jin, H., Xiang, L.-X., & Shao, J.-Z. (2007) · Immunogenetics · doi:10.1007/s00251-007-0232-8 · Cited by 45
Hakuno, F., Fukushima, T., Yoneyama, Y., Kamei, H., Ozoe, A., Yoshihara, H., Yamanaka, D., Shibano, T., Sone, M., Yu, B., et al. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00073 · Cited by 44
Molecular mechanisms of inflammation in obesity-linked insulin resistance
Marette, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802500 · Cited by 44
Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells
Mohan, R., Mao, Y., Zhang, S., Zhang, Y.-W., Xu, C., Gradwohl, G., & Tang, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.650705 · Cited by 44
Socs1 Deficiency Enhances Hepatic Insulin Signaling
Jamieson, E. L., Chong, M. M. W., Steinberg, G. R., Jovanovska, V., Fam, B. C., Bullen, D. V. R., Chen, Y., Kemp, B. E., Proietto, J., Kay, T. W. H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502163200 · Cited by 47
Insulin‐Like Growth Factor I Regulation and Its Actions in Skeletal Muscle
Vassilakos, G., & Barton, E. R. (2018) · Comprehensive physiology · doi:10.1002/cphy.c180010 · Cited by 48
SOCS6 is a selective suppressor of receptor tyrosine kinase signaling
Kabir, N. N., Sun, J., Rönnstrand, L., & Kazi, J. U. (2014) · Tumor Biology · doi:10.1007/s13277-014-2542-4 · Cited by 43
Hepatitis C Virus Infection: Molecular Pathways to Insulin resistance
Parvaiz, F., Manzoor, S., Tariq, H., Javed, F., Fatima, K., & Qadri, I. (2011) · Virology Journal · doi:10.1186/1743-422x-8-474 · Cited by 43
Gerrits, A. J., Gitz, E., Koekman, A. C., Visseren, F. L. J., van Haeften, T. W., & Akkerman, J. N. (2012) · Haematologica · doi:10.3324/haematol.2011.054916 · Cited by 43
Boonloh, K., Kukongviriyapan, U., Pannangpetch, P., Kongyingyoes, B., Senggunprai, L., Prawan, A., Thawornchinsombut, S., & Kukongviriyapan, V. (2014) · Food & Function · doi:10.1039/c4fo00872c · Cited by 43
Role of E3 ubiquitin ligases in insulin resistance
Yang, X., Xiang, D., & Yang, Y. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12677 · Cited by 43
Keegan, A. D., Zamorano, J., Keselman, A. M., & Heller, N. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01037 · Cited by 44
Frendo‐Cumbo, S., Jaldín‐Fincati, J. R., Coyaud, É., Laurent, E. M. N., Townsend, L. K., Tan, J. M. J., Xavier, R. J., Pillon, N. J., Raught, B., Wright, D. C., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009110 · Cited by 44
Negative regulation of cytokine signaling and inflammatory diseases
Inagaki-Ohara, K. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00070-5 · Cited by 41
Carper, M. J., Cade, W. T., Cam, M. C., Zhang, S., Shalev, A., Yarasheski, K. E., & Ramanadham, S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00167.2007 · Cited by 43
Hanada, T., Kinjyo, I., Inagaki-Ohara, K., & Yoshimura, A. (2003) · Springer eBooks · doi:10.1007/s10254-003-0015-z · Cited by 43
Cho, K. W., Zhou, Y., Sheng, L., & Rui, L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00459-10 · Cited by 42
Kershaw, N. J., Laktyushin, A., Nicola, N. A., & Babon, J. J. (2014) · Growth Factors · doi:10.3109/08977194.2013.877005 · Cited by 46
The influence of endotoxemia on the molecular mechanisms of insulin resistance.
Moreira, A. P. B., & Alfenas, R. D. C. G. (2012) · PubMed · doi:10.1590/s0212-16112012000200007 · Cited by 45
Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease
Kaser, S., Ebenbichler, C. F., & Tilg, H. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02327.x · Cited by 42
Muscle wasting: an overview of recent developments in basic research
Palus, S., von Haehling, S., & Springer, J. (2014) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-014-0157-7 · Cited by 42
SOCS3 regulates p21 expression and cell cycle arrest in response to DNA damage
Sitko, J. C., Yeh, B. K., Kim, M., Zhou, H., Takaesu, G., Yoshimura, A., McBride, W. H., Jewett, A., Jamieson, C., & Cacalano, N. A. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.08.011 · Cited by 40
Wensveen, F. M., Šestan, M., Wensveen, T. T., & Polić, B. (2019) · European Journal of Immunology · doi:10.1002/eji.201847895 · Cited by 42
Chapter 6 Crosstalk Between Growth Hormone and Insulin Signaling
Xu, J., & Messina, J. L. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00606-7 · Cited by 40
Fritsche, L., Neukamm, S. S., Lehmann, R., Kremmer, E., Hennige, A. M., Hunder-Gugel, A., Schenk, M., Häring, H., Schleicher, E. D., & Weigert, C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2010 · Cited by 40
Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus
Salvadó, L., Serrano, L., Barroso, E., Palomer, X., & Vázquez‐Carrera, M. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.658370 · Cited by 42
Is insulin signaling molecules misguided in diabetes for ubiquitin–proteasome mediated degradation?
Balasubramanyam, M., Rangasamy, S., & Mohan, V. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-1083-y · Cited by 40
Dynamic Interplay Between Metabolic Syndrome and Immunity
Paragh, G., Seres, I., Harangi, M., & Fülöp, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_13 · Cited by 40
Mechanisms of SOCS3 Phosphorylation upon Interleukin-6 Stimulation
Sommer, U., Schmid, C., Sobota, R. M., Lehmann, U., Stevenson, N. J., Johnston, J. A., Schaper, F., Heinrich, P. C., & Haan, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506008200 · Cited by 42
Metadata
- Authors
- Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 44
- Pages
- 42394-42398
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2069711307
- Cited by
- 904
- References
- 44
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 18 · 2023: 25 · 2022: 35 · 2021: 39 · 2020: 27 · 2019: 29 · 2018: 42 · 2017: 33 · 2016: 48 · 2015: 27 · 2014: 50 · 2013: 51 · 2012: 57
- FWCI
- 30.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- SOCS1, SOCS3, IRS-1, insulin receptor substrate 2, insulin signaling, ubiquitin-mediated proteolysis, SOCS box, inflammation, insulin resistance, impaired glucose tolerance, liver, diabetes mellitus
- MeSH terms
- Suppressor of Cytokine Signaling 1 Protein, Suppressor of Cytokine Signaling 3 Protein, Elongin, Animals, Carrier Proteins, Glucose, Homeostasis, Humans, Insulin Resistance, Male, Mice, Inbred C57BL, Phosphoproteins, Proteins, Repressor Proteins, Transcription Factors, Ubiquitin, Intracellular Signaling Peptides and Proteins, Suppressor of Cytokine Signaling Proteins, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
